N Jewel Samadder1, Karen Curtin2, Thérèse M F Tuohy3, Lisa Pappas3, Ken Boucher3, Dawn Provenzale4, Kerry G Rowe5, Geraldine P Mineau6, Ken Smith6, Richard Pimentel3, Anne C Kirchhoff7, Randall W Burt8. 1. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Medicine (Gastroenterology), University of Utah, Salt Lake City, Utah. Electronic address: Jewel.samadder@hsc.utah.edu. 2. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Medicine (Genetic Epidemiology), University of Utah, Salt Lake City, Utah. 3. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 4. VA Cooperative Studies Epidemiology Center-Durham, Durham VAMC, Durham, North Carolina; Department of Medicine (Gastroenterology), Duke University, Durham, North Carolina. 5. Department of Oncology, Intermountain Healthcare, Salt Lake City, Utah. 6. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Oncological Sciences, University of Utah, Salt Lake City, Utah. 7. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Pediatrics at University of Utah, Salt Lake City, Utah. 8. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Medicine (Gastroenterology), University of Utah, Salt Lake City, Utah; Department of Oncological Sciences, University of Utah, Salt Lake City, Utah.
Abstract
BACKGROUND & AIMS: Colorectal cancers (CRCs) diagnosed within a few years after an index colonoscopy can arise from missed lesions or the development of a new tumor. We investigated the proportion, characteristics, and factors that predict interval CRCs that develop within 6-60 months of colonoscopy. METHODS: We performed a population-based cohort study of Utah residents who underwent colonoscopy examinations from 1995 through 2009 at Intermountain Healthcare or the University of Utah Health System, which provide care to more than 85% of state residents. Colonoscopy results were linked with cancer histories from the Utah Population Database to identify patients who underwent colonoscopy 6-60 months before a diagnosis of CRC (interval cancer). Logistic regression was performed to identify risk factors associated with interval cancers. RESULTS: Of 126,851 patients who underwent colonoscopies, 2659 were diagnosed with CRC; 6% of these CRCs (159 of 2659) developed within 6 to 60 months of a colonoscopy. Sex and age were not associated with interval CRCs. A higher percentage of patients with interval CRC were found to have adenomas at their index colonoscopy (57.2%), compared with patients found to have CRC detected at colonoscopy (36%) or patients who did not develop cancer (26%) (P < .001). Interval CRCs tended to be earlier-stage tumors than those detected at index colonoscopy, and to be proximally located (odds ratio, 2.24; P < .001). Patients with interval CRC were more likely to have a family history of CRC (odds ratio, 2.27; P = .008) and had a lower risk of death than patients found to have CRC at their index colonoscopy (hazard ratio, 0.63; P < .001). CONCLUSIONS: In a population-based study in Utah, 6% of all patients with CRC had interval cancers (cancer that developed within 6 to 60 months of a colonoscopy). Interval CRCs were associated with the proximal colon, earlier-stage cancer, lower risk of death, higher rate of adenoma, and family history of CRC. These findings indicate that interval colorectal tumors may arise as the result of distinct biologic features and/or suboptimal management of polyps at colonoscopy.
BACKGROUND & AIMS:Colorectal cancers (CRCs) diagnosed within a few years after an index colonoscopy can arise from missed lesions or the development of a new tumor. We investigated the proportion, characteristics, and factors that predict interval CRCs that develop within 6-60 months of colonoscopy. METHODS: We performed a population-based cohort study of Utah residents who underwent colonoscopy examinations from 1995 through 2009 at Intermountain Healthcare or the University of Utah Health System, which provide care to more than 85% of state residents. Colonoscopy results were linked with cancer histories from the Utah Population Database to identify patients who underwent colonoscopy 6-60 months before a diagnosis of CRC (interval cancer). Logistic regression was performed to identify risk factors associated with interval cancers. RESULTS: Of 126,851 patients who underwent colonoscopies, 2659 were diagnosed with CRC; 6% of these CRCs (159 of 2659) developed within 6 to 60 months of a colonoscopy. Sex and age were not associated with interval CRCs. A higher percentage of patients with interval CRC were found to have adenomas at their index colonoscopy (57.2%), compared with patients found to have CRC detected at colonoscopy (36%) or patients who did not develop cancer (26%) (P < .001). Interval CRCs tended to be earlier-stage tumors than those detected at index colonoscopy, and to be proximally located (odds ratio, 2.24; P < .001). Patients with interval CRC were more likely to have a family history of CRC (odds ratio, 2.27; P = .008) and had a lower risk of death than patients found to have CRC at their index colonoscopy (hazard ratio, 0.63; P < .001). CONCLUSIONS: In a population-based study in Utah, 6% of all patients with CRC had interval cancers (cancer that developed within 6 to 60 months of a colonoscopy). Interval CRCs were associated with the proximal colon, earlier-stage cancer, lower risk of death, higher rate of adenoma, and family history of CRC. These findings indicate that interval colorectal tumors may arise as the result of distinct biologic features and/or suboptimal management of polyps at colonoscopy.
Authors: Nikolas H Kazmers; Zhe Yu; Tyler Barker; Tyler Abraham; Robin Romero; Michael J Jurynec Journal: J Hand Surg Am Date: 2019-11-22 Impact factor: 2.230
Authors: Swathi Eluri; Alyssa M Parian; Berkeley N Limketkai; Christina Y Ha; Steven R Brant; Sharon Dudley-Brown; Jonathan E Efron; Sandy G Fang; Susan L Gearhart; Michael R Marohn; Stephen J Meltzer; Safar Bashar; Brindusa Truta; Elizabeth A Montgomery; Mark G Lazarev Journal: Dig Dis Sci Date: 2017-06-19 Impact factor: 3.199
Authors: Amandeep K Shergill; Erin E Conners; Kenneth R McQuaid; Sara Epstein; James C Ryan; Janak N Shah; John Inadomi; Ma Somsouk Journal: Gastrointest Endosc Date: 2015-05-01 Impact factor: 9.427
Authors: Jill S Barnholtz-Sloan; Dana E Rollison; Amrita Basu; Alexander D Borowsky; Alex Bui; Jack DiGiovanna; Montserrat Garcia-Closas; Jeanine M Genkinger; Travis Gerke; Marta Induni; James V Lacey; Lisa Mirel; Jennifer B Permuth; Joel Saltz; Elizabeth A Shenkman; Cornelia M Ulrich; W Jim Zheng; Sorena Nadaf; Warren A Kibbe Journal: JCO Clin Cancer Inform Date: 2020-02
Authors: A Tannapfel; D Aust; G B Baretton; H Bläker; I Esposito; C Langner; M Vieth; E Wardelmann; Th Kirchner; P Schirmacher Journal: Pathologe Date: 2015-03 Impact factor: 1.011